Sunovion Pharmaceuticals Inc.

Registered Principal Details

Business Or Interest:
Pharmaceuticals

Lobbying Interests:
All matters affecting the pharmaceuticals and health care industries

CEO Name:
Nobuhiko Tamura
Executive Director

Contact
ER
Eric Rasmussen
84 Waterford Drive
Marlborough, MA 01752
(508) 357-7330
(866) 556-8818
eric.rasmussen@sunovion.com
http://www.sunovion.com

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On
Nancy McKee Exclusive Duties No Authorized On 12/26/2018 Withdrawn On N/A
Gregory Hubbard Exclusive Duties No Authorized On 12/26/2018 Withdrawn On N/A
Katie White Exclusive Duties No Authorized On 12/26/2018 Withdrawn On N/A
Ramie Zelenkova Exclusive Duties No Authorized On 12/26/2018 Withdrawn On N/A

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 24
Assembly Bill 24
Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.

Bill Text and History

For
Notification Date
2/13/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 26
Senate Bill 26
Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.

Bill Text and History

2019 Wisconsin Act 12

For
Notification Date
2/13/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Budget Bill Subjects

Health Services: Medicaid Services
Biennial budget bill treatment of matter relating to
Health Services: Medicaid Services

Notification Date
5/8/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Insurance: Departmentwide
Biennial budget bill treatment of matter relating to
Insurance: Departmentwide

Notification Date
3/6/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Topics Not Yet Assigned A Bill Or Rule Number

COVID-19 related issues.
Development, drafting or introduction of a proposal relating to
COVID-19 related issues.

Action Intended To Affect
Both Legislative matter and rule

Notification Date
3/25/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Governor's Prescription Drug Task Force
Development, drafting or introduction of a proposal relating to
Governor's Prescription Drug Task Force

Action Intended To Affect
Both Legislative matter and rule

Notification Date
2/5/2020
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

DHS waivers of federal law, pilot programs, demonstration projects and rate adjustments.
Development, drafting or introduction of a proposal relating to
DHS waivers of federal law, pilot programs, demonstration projects and rate adjustments.

Action Intended To Affect
Both Legislative matter and rule

Notification Date
1/27/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Mental health and mental health access
Development, drafting or introduction of a proposal relating to
Mental health and mental health access

Action Intended To Affect
Both Legislative matter and rule

Notification Date
12/21/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Access to prescription drugs
Development, drafting or introduction of a proposal relating to
Access to prescription drugs

Action Intended To Affect
Both Legislative matter and rule

Notification Date
12/21/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Medicaid programs
Development, drafting or introduction of a proposal relating to
Medicaid programs

Action Intended To Affect
Both Legislative matter and rule

Notification Date
12/21/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Step Therapy
Development, drafting or introduction of a proposal relating to
Step Therapy

Action Intended To Affect
Both Legislative matter and rule

Notification Date
12/21/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Total Lobbying Effort

  2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
Total Lobbying Expenditures 2019
January - June
$15,720.86
2019
July - December
$2,357.43
2020
January - June
$12,812.50
2020
July - December
$5,829.00
Total $36,719.79
Total Hours Communicating 2019
January - June
32.25
2019
July - December
1.50
2020
January - June
2.50
2020
July - December
2.00
Total 38.25
Total Hours Other 2019
January - June
31.00
2019
July - December
9.25
2020
January - June
48.75
2020
July - December
24.25
Total 113.25

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.
2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
35%
2019
July - December
2020
January - June
2020
July - December
Total 15%
Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.
2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
35%
2019
July - December
10%
2020
January - June
2020
July - December
Total 15%

Budget Bill Subjects

2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
10%
2019
July - December
2020
January - June
2020
July - December
Total 4%

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
2019
July - December
2020
January - June
70%
2020
July - December
60%
Total 34%
2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
2019
July - December
2020
January - June
2020
July - December
10%
Total 2%

Minor Efforts

(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)

Minor Efforts
2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
10%
2019
July - December
10%
2020
January - June
10%
2020
July - December
10%
Total 10%

Other Matters

Includes time spent on:

  • Gubernatorial nominations
  • Matters on which the organization made no lobbying communication

Other Matters
2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
10%
2019
July - December
80%
2020
January - June
20%
2020
July - December
20%
Total 20%

Filed Statements of Lobbying Activity and Expenditures